Atosiban impurity 11

Atosiban Impurity 11 is a related peptide variant formed during atosiban synthesis or degradation. Changes in residue architecture affect chromatographic mobility and folding. Researchers use it to validate analytical resolution and impurity thresholds. Applications include QC development, process monitoring, and degradation-pathway research.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: Z10-101-170

Synonyms/Alias:Atosiban impurity 11,Mpr-DTyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-ol(Mpr1Cys6 bridge)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C86H134N22O24S4
M.W/Mr.
1988.39

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesiscGMP Peptide ServiceCustom Conjugation ServicePeptide CDMOPeptide Analysis ServicesEpitope Mapping ServicesPeptide Modification ServicesPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers